Trademark Board Manual of Procedure, Third Edition
The United States Patent and Trademark Office ("USPTO") issued the third edition of the Trademark Board Manual of Procedure ("TBMP") on May 6, 2011.
- Task
- Read the news
- Patent or trademark
- both
- Legacy system
- —
- Current entry point
- www.federalregister.gov/documents/2011/07/01/2011-16605/trademark-board-manual-of-procedure-third-edition (permanent link in the Federal Register, verified 2026-09-30)
- Legacy system and where it moved
- No legacy system name mention in title or summary )
- Fee
- No fee mention in title or summary )
- What you need (account or API key)
- No account or key mention in title or summary )
- Published
- 2011-07-01
- Document type
- Notice
- Source
- USPTO documents published in the Federal Register (Federal Register API)(retrieved 2026-10-06)
Everything in the same category
Read the news (all 1988) · both (all 2333)
Related entry points
- Trademark Board Manual of Procedure, Third Edition, Revision 1
- Trademark Manual of Examining Procedure, Eighth Edition
- Revision of Patent Term Adjustment Provisions Relating to Appellate Review
- Revision of the Duty To Disclose Information in Patent Applications and Reexamination Proceedings
- Grant of Certificate of Interim Extension of the Term of U.S. Patent No. 4,229,449: Roboxetine Mesylate
- Grant of Interim Extension of the Term of U.S. Patent No. 4,567,264; Ranolazine
- Grant of Interim Extension of the Term of U.S. Patent No. 4,919,140; AndaraTM OFSTM System
- Grant of Interim Extension of the Term of U.S. Patent No. 5,407,914; SURFAXIN® (Lucinactant)
- Changes To Implement the Preissuance Submissions by Third Parties Provision of the Leahy-Smith America Invents Act
- Changes To Implement the Preissuance Submissions by Third Parties Provision of the Leahy-Smith America Invents Act
- Grant of Interim Extension of the Term of U.S. Patent No. 5,454,779; ResQPump®/ResQPOD® ITD
- Grant of Interim Extension of the Term of U.S. Patent No. 4,585,597; ANTHÉLIOS ® SP Topical Cream (Mexoryl ® SX (Ecamsule))
- Grant of Interim Extension of the Term of U.S. Patent No. 4,591,585; atamestane
- Grant of Interim Extension of the Term of U.S. Patent No. 4,650,787; Sanvar®
- Grant of Interim Extension of the Term of U.S. Patent No. 4,971,802; MIFAMURTIDE
- Request for Comments on Director Review, Precedential Opinion Panel Review, and Internal Circulation and Review of Patent Trial and Appeal Board Decisions